Neoadjuvant chemoradiotherapy with or without panitumumab in patients with wild-type KRAS, locally advanced rectal cancer (LARC): a randomized, multicenter, phase II trial SAKK 41/07 - Helbling, D; Bodoky, G; Gautschi, O (Ann Oncol, 2013)
, et al.